Ken Fisher's NVS Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 7.47 M shares of Novartis AG (NVS) worth $1.03 B, representing 0.35% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in NVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 4.76 M shares. Largest reduction occurred in Q3 2022, reducing 10.15 M shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Novartis (NVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novartis (NVS) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +226,484 | Add 3.13% | 7.47 M | $137.87 |
| Q3 2025 | +117,952 | Add 1.66% | 7.24 M | $128.24 |
| Q2 2025 | +358,282 | Add 5.30% | 7.12 M | $121.01 |
| Q1 2025 | +4.76 M | Add 237.66% | 6.76 M | $111.48 |
| Q4 2024 | +296,950 | Add 17.41% | 2 M | $97.31 |
| Q3 2024 | +231,851 | Add 15.73% | 1.71 M | $115.02 |
| Q2 2024 | +26,283 | Add 1.82% | 1.47 M | $106.46 |
| Q1 2024 | +17,266 | Add 1.21% | 1.45 M | $96.73 |
| Q4 2023 | +22,397 | Add 1.59% | 1.43 M | $100.97 |
| Q3 2023 | +544,682 | Add 63.08% | 1.41 M | $101.86 |
| Q2 2023 | +19,342 | Add 2.29% | 863,530 | $100.91 |
| Q1 2023 | -36,129 | Reduce 4.10% | 844,188 | $92.00 |
| Q4 2022 | -213,064 | Reduce 19.49% | 880,317 | $90.72 |
| Q3 2022 | -10.15 M | Reduce 90.28% | 1.09 M | $76.01 |
| Q2 2022 | +375,047 | Add 3.45% | 11.25 M | $84.53 |
| Q1 2022 | +486,367 | Add 4.68% | 10.87 M | $87.75 |
| Q4 2021 | +79,637 | Add 0.77% | 10.38 M | $87.47 |
| Q3 2021 | +342,603 | Add 3.44% | 10.31 M | $81.78 |
| Q2 2021 | +304,823 | Add 3.16% | 9.96 M | $91.24 |
| Q1 2021 | +319,803 | Add 3.42% | 9.66 M | $85.48 |
| Q4 2020 | +273,520 | Add 3.02% | 9.34 M | $94.43 |
| Q3 2020 | +236,451 | Add 2.68% | 9.06 M | $86.96 |
| Q2 2020 | +292,961 | Add 3.43% | 8.83 M | $87.34 |
| Q1 2020 | +113,098 | Add 1.34% | 8.53 M | $82.45 |
| Q4 2019 | +106,786 | Add 1.28% | 8.42 M | $94.69 |
| Q3 2019 | +247,749 | Add 3.07% | 8.31 M | $86.90 |
| Q2 2019 | -662,888 | Reduce 7.59% | 8.07 M | $91.31 |
| Q1 2019 | +237,774 | Add 2.80% | 8.73 M | $86.15 |
| Q4 2018 | +205,963 | Add 2.49% | 8.49 M | $76.89 |
| Q3 2018 | +111,395 | Add 1.36% | 8.29 M | $77.20 |
| Q2 2018 | +355,766 | Add 4.55% | 8.17 M | $67.69 |
| Q1 2018 | +211,871 | Add 2.79% | 7.82 M | $72.45 |
| Q4 2017 | +204,944 | Add 2.77% | 7.61 M | $75.23 |
| Q3 2017 | +141,787 | Add 1.95% | 7.4 M | $76.93 |
| Q2 2017 | +428,836 | Add 6.28% | 7.26 M | $74.79 |
| Q1 2017 | +52,232 | Add 0.77% | 6.83 M | $66.55 |
| Q4 2016 | +10,848 | Add 0.16% | 6.78 M | $65.27 |
| Q3 2016 | -333,116 | Reduce 4.69% | 6.77 M | $70.75 |
| Q2 2016 | +85,421 | Add 1.22% | 7.1 M | $73.75 |
| Q1 2016 | +109,597 | Add 1.59% | 7.02 M | $67.79 |
| Q4 2015 | +63,258 | Add 0.92% | 6.91 M | $77.10 |
| Q3 2015 | +86,569 | Add 1.28% | 6.84 M | $82.37 |
| Q2 2015 | +71,888 | Add 1.08% | 6.76 M | $88.12 |
| Q1 2015 | -19,129 | Reduce 0.29% | 6.69 M | $88.36 |
| Q4 2014 | -8,781 | Reduce 0.13% | 6.7 M | $83.03 |
| Q3 2014 | +50,521 | Add 0.76% | 6.71 M | $84.35 |
| Q2 2014 | +90,035 | Add 1.37% | 6.66 M | $81.12 |
| Q1 2014 | +120,153 | Add 1.86% | 6.57 M | $76.18 |
| Q4 2013 | +62,239 | Add 0.97% | 6.45 M | $72.03 |
| Q3 2013 | +110,180 | Add 1.75% | 6.39 M | $68.74 |
| Q2 2013 | +6.28 M | Add 0.00% | 6.28 M | $63.36 |
Ken Fisher's Novartis Investment FAQs
Ken Fisher first purchased Novartis AG (NVS) in Q2 2013, acquiring 6,279,872 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Novartis AG (NVS) for 51 quarters since Q2 2013.
Ken Fisher's largest addition to Novartis AG (NVS) was in Q2 2013, adding 6,279,872 shares worth $397.89 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 7,465,850 shares of Novartis AG (NVS), valued at approximately $1.03 B.
As of the Q4 2025 filing, Novartis AG (NVS) represents approximately 0.35% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Novartis AG (NVS) was 11,246,080 shares, as reported at the end of Q2 2022.